These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 34440471)
1. Endogenous Mammalian Cardiotonic Steroids-A New Cardiovascular Risk Factor?-A Mini-Review. Słabiak-Błaż N; Piecha G Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440471 [TBL] [Abstract][Full Text] [Related]
2. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension. Paczula A; Więcek A; Piecha G Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099 [TBL] [Abstract][Full Text] [Related]
5. Whither digitalis? What we can still learn from cardiotonic steroids about heart failure and hypertension. Blaustein MP; Gottlieb SS; Hamlyn JM; Leenen FHH Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1281-H1295. PubMed ID: 36367691 [TBL] [Abstract][Full Text] [Related]
11. Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence? Orlov SN; Tverskoi AM; Sidorenko SV; Smolyaninova LV; Lopina OD; Dulin NO; Klimanova EA Genes Dis; 2021 May; 8(3):259-271. PubMed ID: 33997173 [TBL] [Abstract][Full Text] [Related]
12. The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease. Pavlovic D Nephron Clin Pract; 2014; 128(1-2):11-21. PubMed ID: 25341357 [TBL] [Abstract][Full Text] [Related]
13. The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling? Xie JX; Shapiro AP; Shapiro JI Front Endocrinol (Lausanne); 2014; 5():97. PubMed ID: 25101054 [TBL] [Abstract][Full Text] [Related]
14. Na+,K+-ATPase as a Target for Treatment of Tissue Fibrosis. Orlov SN; La J; Smolyaninova LV; Dulin NO Curr Med Chem; 2019; 26(3):564-575. PubMed ID: 28625151 [TBL] [Abstract][Full Text] [Related]
15. Cardiotonic Steroids Stimulate Macrophage Inflammatory Responses Through a Pathway Involving CD36, TLR4, and Na/K-ATPase. Chen Y; Huang W; Yang M; Xin G; Cui W; Xie Z; Silverstein RL Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1462-1469. PubMed ID: 28619997 [TBL] [Abstract][Full Text] [Related]
16. Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1 Marck PV; Pessoa MT; Xu Y; Kutz LC; Collins DM; Yan Y; King C; Wang X; Duan Q; Cai L; Xie JX; Lingrel JB; Xie Z; Tian J; Pierre SV Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801629 [TBL] [Abstract][Full Text] [Related]
17. The Na(+)/K(+)-ATPase as [K(+)](o) sensor: Role in cardiovascular disease pathogenesis and augmented production of endogenous cardiotonic steroids. Akimova O; Tremblay J; Hamet P; Orlov SN Pathophysiology; 2006 Dec; 13(4):209-16. PubMed ID: 16857351 [TBL] [Abstract][Full Text] [Related]
18. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Schoner W; Scheiner-Bobis G Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630 [TBL] [Abstract][Full Text] [Related]
19. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Schoner W; Scheiner-Bobis G Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345 [TBL] [Abstract][Full Text] [Related]
20. Snakes exhibit tissue-specific variation in cardiotonic steroid sensitivity of Na Mohammadi S; Petschenka G; French SS; Mori A; Savitzky AH Comp Biochem Physiol B Biochem Mol Biol; 2018 Mar; 217():21-26. PubMed ID: 29223875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]